Jb Capital LLC Seagen Inc. Transaction History

Jb Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$108.81 - $179.33 $3,373 - $5,559	31 Added 2.21%	1,432 $253,000
Q1 2022 Apr 19, 2022	SELL	$119.61 - $157.85 $28,467 - $37,568	-238 Reduced 14.52%	1,401 $202,000
Q4 2021 Feb 02, 2022	SELL	$142.57 - $190.86 $997 - $1,336	-7 Reduced 0.43%	1,639 $253,000
Q3 2021 Dec 08, 2021	BUY	$142.45 - $169.82 $234,472 - $279,523	1,646 New	1,646 $279,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Jb Capital LLC with notifications on news.